IsoRay Announces First Quarter Fiscal 2019 Financial Results
Revenue for the first quarter fiscal 2019 grew 29% to $1.56 million versus $1.21 million in the prior year comparable period.
- Home
- About
- Brachytherapy
Patient Information
Clinician Information
Cesium 131 Products
- Theranostics
- Newsroom
- Investor Center
- Contact us
